Company profile
Athebio company profile
Athebio is a biotechnology company that designs and develops binding proteins for drug developers. Its modular platform enables partners to generate custom binders for diverse therapeutic areas, including oncology, gene therapy, and radioligand development. Athebio collaborates with global biopharma companies such as REGENXBIO, POINT Biopharma, and 3T Biosciences. The company’s mission is to expand the therapeutic potential of DARPins across multiple modalities. Through its platform-as-a-service approach, it accelerates the path from molecular design to clinical translation.
Business identity
- Website
- https://athebio.com
- Contact email
- [email protected]
- Phone number
- +41 44 508 08 28
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Founded
- 2019-01-01, Year
Headquarters
- Headquarters
- Schlieren, Zurich, Switzerland
- Postal code
- 8952
- Country code
- CH
- Continent
- Europe